With the rapidly expanding interest in heavy-duty electric trucks, Toyota Motor North America (TMNA) and Hino USA have agreed to jointly develop a Class 8 fuel cell electric truck (FCET) for the North American market. The companies will leverage the newly developed Hino XL Series chassis with Toyota’s proven fuel cell technology to deliver exceptional… Continue reading Toyota and Hino to develop Class 8 fuel cell electric truck for North America
Category: Automotive
@Nio: 000145
NIO delivered 4,708 vehicles in September 2020, increasing by 133.2% year-over-year NIO delivered 12,206 vehicles in the three months ended September 2020, increasing by 154.3% year-over-year NIO delivered 26,375 vehicles in 2020 in total, increasing by 113.7% year-over-year NIO began the deliveries of the EC6 in September 2020 and cumulative deliveries of ES8, ES6 and… Continue reading @Nio: 000145
Amid job cuts, Ford workers get merit pay delayed by coronavirus
Ford Motor Co. plans to “be applying merit pay increases, delayed early in the pandemic, in October,” a company official confirmed to the Free Press. T.R. Reid, Ford spokesman, declined to say how many workers would receive the increase or the size of merit pay. “Merit pay increases vary by person, based on achievement of objectives.… Continue reading Amid job cuts, Ford workers get merit pay delayed by coronavirus
Uber secured its London future in a landmark court case — but the mayor warned he would scrutinize the taxi service and take ‘swift action’ if needed
Mayor Sadiq Khan of London on Monday responded to a court victory by Uber by saying he would keep a close eye on the company to ensure it’s meeting safety requirements. Uber won an appeal against the regulator Transport for London in court Monday and will now be issued a new operating license. Transport for… Continue reading Uber secured its London future in a landmark court case — but the mayor warned he would scrutinize the taxi service and take ‘swift action’ if needed
Exclusive: GM Can Manage an EV’s Batteries Wirelessly—and Remotely
Original Article
A New Way For Autonomous Racing Cars to Control Sideslip
Original Article
Gestamp endured the toughest semester in its history30.07.2020Gestamp has presented its results for Q2 and H1 2020 in which the company reacted quickl…
Gestamp, the multinational company specialized in the design, development and manufacture of highly engineered metal components for the automotive industry, has presented its results for Q2 and H1 2020 in which the company reacted quickly to an unprecedented crash in the market due to COVID-19 and has demonstrated its flexible and resilient business model. Specifically,… Continue reading Gestamp endured the toughest semester in its history30.07.2020Gestamp has presented its results for Q2 and H1 2020 in which the company reacted quickl…
Schaeffler to refinance upcoming debt maturities
2020-10-05 | Herzogenaurach Bond issue with total volume of EUR 1.5 billion Issuance proceeds to be used for refinancing of upcoming debt maturities Treasury management exercise results in enhanced debt maturity profile for the Schaeffler Group The global automotive and industrial supplier Schaeffler today successfully placed corporate bonds with a total volume of EUR 1.5… Continue reading Schaeffler to refinance upcoming debt maturities
Schaeffler refinanziert nächste Fälligkeiten
2020-10-05 | Herzogenaurach Anleiheemission mit Gesamtvolumen von insgesamt 1,5 Milliarden Euro Emissionserlöse refinanzieren zukünftige Verbindlichkeiten Fälligkeitsprofil im Rahmen des Treasury-Managements der Schaeffler Gruppe verbessert Der weltweit tätige Automobil- und Industriezulieferer Schaeffler hat heute erfolgreich Unternehmensanleihen in einem Gesamtvolumen von 1,5 Milliarden Euro bei internationalen Investoren platziert. Die Platzierung der Anleihen erfolgte unter dem Debt-Issuance-Programm der… Continue reading Schaeffler refinanziert nächste Fälligkeiten
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
October 2nd, 2020 Xconomy National — As the one-year anniversary of Bristol-Myers Squibb Company’s $74bn acquisition of Celgene Corporation approaches, Scrip spoke with chief medical officer Samit Hirawat about the big pharma’s achievements during a challenging period in which the COVID-19 pandemic threatened to derail clinical trials and a national spotlight on racial inequality shined… Continue reading Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity